BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19477367)

  • 1. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
    Laurent S; Boutouyrie P
    J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
    [No Abstract]   [Full Text] [Related]  

  • 2. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blocker-induced heart rate lowering, cardioprotection, and hypertension.
    Khan SS
    J Am Coll Cardiol; 2009 Jun; 53(22):2104-5; author reply 2106-7. PubMed ID: 19477368
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
    Lavie CJ; Messerli FH; Milani RV
    J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
    [No Abstract]   [Full Text] [Related]  

  • 6. Current role of beta-blockers in the treatment of hypertension.
    Aronow WS
    Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives.
    Westhoff TH; Franke N; Schmidt S; Vallbracht-Israng K; Zidek W; Dimeo F; van der Giet M
    J Hum Hypertens; 2007 Jun; 21(6):486-93. PubMed ID: 17330056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockers in hypertension and cardiovascular disease.
    Ong HT
    BMJ; 2007 May; 334(7600):946-9. PubMed ID: 17478848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].
    Sawicki PT; Berger M
    Dtsch Med Wochenschr; 1992 May; 117(22):875-9. PubMed ID: 1350758
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 12. Are beta blockers effective first-line treatments for hypertension?
    Cayley WE
    Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta blockers for hypertension. No negative influence on insulin resistance].
    MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Blockers and hypertension: a therapeutic reappraisal.
    Panjrath GS; Sawhney S; Messerli FH
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):26-33. PubMed ID: 19667708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting heart rate and cardiovascular disease: the beta-blocker-hypertension paradox.
    Messerli FH; Bangalore S
    J Am Coll Cardiol; 2008 Jan; 51(3):330-1; author reply 331-2. PubMed ID: 18206747
    [No Abstract]   [Full Text] [Related]  

  • 16. Atenolol is dead: long live beta-blockade.
    Cockcroft JR
    J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
    Aenishänslin W; Pestalozzi-Kerpel J; Dubach UC; Imhof PR; Turri M
    Eur J Clin Pharmacol; 1972 Jun; 4(3):177-81. PubMed ID: 4144064
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta blockers in primary hypertension: Do age and type of beta-blocker matter?
    Lindholm LH; Carlberg B; Samuelsson O
    J Hypertens; 2006 Nov; 24(11):2143-5. PubMed ID: 17053530
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blockers and the treatment of hypertension.
    Williams B
    J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.